首页 | 本学科首页   官方微博 | 高级检索  
检索        

康莱特注射液与DF方案联用治疗食管癌临床观察
引用本文:李醒亚,申淑景,樊青霞.康莱特注射液与DF方案联用治疗食管癌临床观察[J].中国肿瘤临床,1999,26(4):296-297.
作者姓名:李醒亚  申淑景  樊青霞
作者单位:河南医科大学第一附属医院
摘    要:为了观察康莱特与化疗联用对食管癌的治疗效果。方法将95例中晚期食管癌患者胡机分入康莱特联用DDP+5-FU组和单纯DDP+5-FU化疗组。结果:1)两组有效率分别为73%和53%,差异显著,2)联用组治疗前后KPS评分改善及稳定者也明显高于单纯化疗组;3)化疗结束后联用组有3/4患者能够及时放疗,而单纯化疗组只有不足1/2患者能按放疗。结论长期应用康莱特性使患者KPS提高或保持稳定。有助于提高疗效

关 键 词:食管癌  康莱特  药物疗法  联合疗法  DF方案

Combination of Kanglaite Injection and DDP - 5 - Fu Chemotherapyin the Treatent of Esophageal Cancer
Li Xingya ,Shen Shujing, Fan Qingxia et al.Combination of Kanglaite Injection and DDP - 5 - Fu Chemotherapyin the Treatent of Esophageal Cancer[J].Chinese Journal of Clinical Oncology,1999,26(4):296-297.
Authors:Li Xingya  Shen Shujing  Fan Qingxia
Abstract:The aim of the trial was to evaluate the curative effect of Kanlaite injection(KLT) onesophageal carcinoma. Ninety - five patients with esophageal cancer were divided into the KLT - DDP/5 - Fu combination treatment group of 44 cases and the chemotherapy alone group of sl cases. The re-sults showed that ( 1 ) The effective rate (CR PR) in combination treatment group was 73% which wassignificantly higher than 63% of the control group (P<0. 05) . (2) The change of general condition af-ter treatment had marked difference (P< 0.01) . (3) 3/4 of cases in the combination treatment groupbegan radiotherapy immediately and more than 1/2 of the patients of control group had delayed one week.
Keywords:Esophageal cancer Kanlaite injection Combination chemotherapy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号